Nathalie Bonnefoy
Overview
Explore the profile of Nathalie Bonnefoy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruciamacchie M, Garambois V, Vie N, Bessede T, Michaud H, Chepeaux L, et al.
Br J Cancer
. 2024 Nov;
132(2):222-235.
PMID: 39613844
Background: In pancreatic ductal adenocarcinoma (PDAC), the dense stroma rich in cancer-associated fibroblasts (CAFs) and the immunosuppressive microenvironment confer resistance to treatments. To overcome such resistance, we tested the combination...
2.
Ropert B, Bannwarth S, Genin E, Vaillant-Beuchot L, Lacas-Gervais S, Hounoum B, et al.
Brain
. 2024 Oct;
PMID: 39478664
The identification of a point mutation (p.Ser59Leu) in the CHCHD10 gene was the first genetic evidence that mitochondrial dysfunction can trigger motor neuron disease. Since then, we have shown that...
3.
Dinh N, Bonnefoy N
IUBMB Life
. 2023 Dec;
76(7):397-419.
PMID: 38117001
Schizosaccharomyces pombe (fission yeast) is an attractive model for mitochondrial research. The organism resembles human cells in terms of mitochondrial inheritance, mitochondrial transport, sugar metabolism, mitogenome structure and dependence of...
4.
Ursino C, Mouric C, Gros L, Bonnefoy N, Faget J
Front Immunol
. 2023 May;
14:1170321.
PMID: 37180110
Immune checkpoint blockade represents the latest revolution in cancer treatment by substantially increasing patients' lifetime and quality of life in multiple neoplastic pathologies. However, this new avenue of cancer management...
5.
Bonnefoy N, Remacle C
Methods Mol Biol
. 2023 Feb;
2615:345-364.
PMID: 36807803
Chlamydomonas reinhardtii and Saccharomyces cerevisiae are currently the two micro-organisms in which genetic transformation of mitochondria is routinely performed. The generation of a large variety of defined alterations as well...
6.
Glasson Y, Chepeaux L, Dume A, Jay P, Pirot N, Bonnefoy N, et al.
Front Immunol
. 2023 Feb;
13:1011617.
PMID: 36741363
Currently, the study of resistance mechanisms and disease progression in cancer relies on the capacity to analyze tumors as a complex ecosystem of healthy and malignant cells. Therefore, one of...
7.
Glasson Y, Chepeaux L, Dume A, Lafont V, Faget J, Bonnefoy N, et al.
Semin Immunopathol
. 2023 Jan;
45(1):17-28.
PMID: 36598557
Solid tumors have a dynamic ecosystem in which malignant and non-malignant (endothelial, stromal, and immune) cell types constantly interact. Importantly, the abundance, localization, and functional orientation of each cell component...
8.
Robert M, Chepeaux L, Glasson Y, Dume A, Sannier A, Papo T, et al.
Autoimmun Rev
. 2022 Oct;
22(1):103216.
PMID: 36280094
No abstract available.
9.
Bobrie A, Massol O, Ramos J, Mollevi C, Lopez-Crapez E, Bonnefoy N, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230752
Background: Triple-negative breast cancers (TNBCs) have a worse prognosis, but might respond to immunotherapies. Macrophages are plastic cells that can adopt various phenotypes and functions. Although they are a major...
10.
Herbert C, Labarre-Mariotte S, Cornu D, Sophie C, Panozzo C, Michel T, et al.
Nucleic Acids Res
. 2021 Oct;
49(19):11145-11166.
PMID: 34634819
Mitochondrial mRNAs encode key subunits of the oxidative phosphorylation complexes that produce energy for the cell. In Saccharomyces cerevisiae, mitochondrial translation is under the control of translational activators, specific to...